ALZN - Alzamend Neuro, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
2.22 0.1 (4.56%)	---	---	---	0.01 (0.45%)	0.13 (5.76%)	0.0 (0.0%)	0.0 (0.0%)

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -1.28
Diluted EPS:: -1.28
Basic P/E:: -1.8134
Diluted P/E:: -1.8134
RSI(14) 1m:: 0.0
VWAP:: 2.32
RVol:: 0.3426

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	2.37 +0.02 (+1.02%)	Oct 15 15:59
1m	Price increase 1m	2.38 +0.04 (+1.71%)	Oct 15 15:58
1m	Price increase 1m	2.29 +0.04 (+1.77%)	Oct 15 14:36